172 related articles for article (PubMed ID: 6884955)
1. [Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases].
Nolte D; Dusik B
Fortschr Med; 1983 Jul; 101(25):1203-6. PubMed ID: 6884955
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of two long-acting theophylline preparations in daily evening administration].
Holzer R
Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
Kaik G
Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
[TBL] [Abstract][Full Text] [Related]
4. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].
Gatto PG; Bruzzoni A; Valenti V
Clin Ter; 1989 Jul; 130(1):45-9. PubMed ID: 2529079
[TBL] [Abstract][Full Text] [Related]
5. Short-acting versus a long-acting preparation of theophylline ('Xantivent') in the treatment of reversible bronchospasm.
Andrasch R; Schmitz-Schumann M
Pharmatherapeutica; 1984; 3(10):668-77. PubMed ID: 6463066
[TBL] [Abstract][Full Text] [Related]
6. The tolerability of a new oral controlled release theophylline preparation in patients with obstructive airways diseases.
Nolte D; Dusik B
Br J Clin Pract Suppl; 1984; 32():18-21. PubMed ID: 6432018
[No Abstract] [Full Text] [Related]
7. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
Fontana G; Cresci F; Lo Sapio P; Panuccio P
Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
[TBL] [Abstract][Full Text] [Related]
8. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E
Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466
[TBL] [Abstract][Full Text] [Related]
9. [Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline].
Gandola L; Aiolfi S; Soccini F; Patrini G; Capellini G; Scartabellati A; Ghio L; Mauri F
Clin Ter; 1989 Dec; 131(5):293-7. PubMed ID: 2532583
[TBL] [Abstract][Full Text] [Related]
10. [Prescription of Theostat 300 as a single evening dose].
Germouty J; Bida C; Moreau L
Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
[TBL] [Abstract][Full Text] [Related]
11. [Long-term therapy with a retard theophylline preparation].
Keller A; Bömches B; Kandt D
Fortschr Med; 1995 May; 113(13):197-202. PubMed ID: 7782018
[TBL] [Abstract][Full Text] [Related]
12. The effects of inhaled albuterol and oral theophylline on gastroesophageal reflux in patients with gastroesophageal reflux disease and obstructive lung disease.
Ruzkowski CJ; Sanowski RA; Austin J; Rohwedder JJ; Waring JP
Arch Intern Med; 1992 Apr; 152(4):783-5. PubMed ID: 1558436
[TBL] [Abstract][Full Text] [Related]
13. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
Baronti A; Verdiani P; Di Carlo S
Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
[No Abstract] [Full Text] [Related]
14. Long-term therapy with sustained-release theophylline.
Myhre KI; Arnulf V; Walstad RA
Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
[TBL] [Abstract][Full Text] [Related]
15. [Clinical effectiveness of delayed-action theophylline preparations].
Tsoĭ AN; Gavrilenko LN; Bogovskiĭ BP; Semenova LG; Iuldasheva LI
Klin Med (Mosk); 1990 Sep; 68(9):72-5. PubMed ID: 2290338
[TBL] [Abstract][Full Text] [Related]
16. [A single dose of theophylline in the evening in chronic obstructive airway disease. Serum concentration and lung function parameter].
Kaik G
Fortschr Med; 1984 Nov; 102(43):1120-2. PubMed ID: 6510864
[TBL] [Abstract][Full Text] [Related]
17. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
[No Abstract] [Full Text] [Related]
18. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
Grassi V; Nicora M; Beretta A
Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
[TBL] [Abstract][Full Text] [Related]
19. Clinical results obtained from a new controlled release theophylline preparation.
Nolte D
Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
[No Abstract] [Full Text] [Related]
20. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
Harder S; Staib AH; Stauder J
Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931
[No Abstract] [Full Text] [Related]
[Next] [New Search]
